Pharmaceutical Industry Shifts Focus to Oral Weight-Loss Medications

The pharmaceutical sector is increasingly optimistic about the future of weight-loss treatments, with a significant shift from injectable medications to more accessible pill forms, potentially expanding the market to $200 billion by the decade's end.

15 Feb, 12:00 — 15 Feb, 12:00

Coverage (1 source)

The Guardian15 Feb, 12:00

Weight-loss race: how switch from injections to pills is expanding big pharma’s hopes

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade

By Julia Kollewe

Read at source →